A carregar...
Secukinumab induced Behçet’s syndrome: a report of two cases
Secukinumab is a human monoclonal antibody against IL-17A that has been shown to be effective in psoriasis, psoriatic arthritis and ankylosing spondylitis (AS). On the other hand, in randomized controlled trials among patients with Crohn’s disease (CD) and uveitis due to Behçet’s syndrome (BS) treat...
Na minha lista:
| Publicado no: | Oxf Med Case Reports |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6544425/ https://ncbi.nlm.nih.gov/pubmed/31198577 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/omcr/omz041 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|